Conclusion
DCIS is rare in men and the lack of standardized diagnostic procedures and evidence-based treatment guidelines may contribute to poorer outcomes compared to women. The research is limited, and a lack of randomized control trials cannot inform standard of care. The management and the overall outcome of male breast cancer can be improved through early detection screening, genetic counseling, and high-quality treatment.3 These changes may help to guide challenging decisions and cases of male breast cancer.